Research in Molecular and Cellular Biosciences
The Center is designed to enhance and synergize USM’s ongoing contributions to high-quality research in molecular biosciences and biotechnology. As an R1 research intensive institution, it is critical to build areas of strength that will enhance the visibility of the research enterprise at USM by obtaining more research grants, publishing more high-quality research articles, and providing high quality education and research to undergraduate and graduate students. The Center is built upon our existing strength in elucidating fundamental questions in cell and molecular biology, ranging from stem cell differentiation, HIV replication, mast cell degranulation, RNA biology, pathogen-host interaction to neurodegenerative and vector-born diseases.
Being unique to the gulf coast region, CMCB is focused on expanding the research frontiers in Biosciences by advanced research, infrastructure development, and enriching graduate student education and training by embracing creativity and rigor.
in competitive extramural funding
publications in 2019
- The Center represents a concentration of competitive research programs that focus on microbiology, molecular and cellular function, as well are infectious or neurodegenerative diseases.
- The Center provides competitive and comprehensive training for our graduate students.
- Center researchers are funded by most funding agencies such National Institutes of Health, National Science Foundation, The United States Department of Agriculture, and other foundations.
Our facilities provide a unique infrastructure to support interdisciplinary research, including laboratory space and high-end scientific equipment.
Researchers at USM’s Center for Molecular and Cellular Biosciences and the Mississippi IDeA Network of Biomedical Research Excellence (INBRE), housed at USM, are providing technical laboratory support through preparing viral transport media (VTM) that has been used by Forrest General Hospital and Hattiesburg Clinic to transport samples to outside labs and developing a workflow to perform up to 50 high-priority tests a day, with a turn-around time of 24 hours or less, and with the possibility of scaling up if urgently needed.